Axsome Therapeutics to Report Second Quarter 2026 Financial Results on August 10

Go back to Axsome Therapeutics to Report Second Quarter 2026 Financial Results on August 10
(NASDAQ: AXSM) Delayed: 240.55 +0.93 (0.39%)
Previous Close $239.62    52 Week High $15.74 
Open $239.00    52 Week Low $5.37 
Day High $244.60    P/E N/A 
Day Low $237.00    EPS $0.00 
Volume 266,018